Ori Biotech
Developed a proprietary, flexible manufacturing platform that closes, automates and standardises manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial scale manufacturing.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD545—818m (Dealroom.co estimates Jan 2022.)
Company register number 09757696
London England (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m |
| % growth | - | 50 % | 8600 % | 19 % | 28 % |
| EBITDA | - | (3.9m) | (18.5m) | (32.9m) | - |
| % EBITDA margin | - | (194104 %) | (10654 %) | (15842 %) | - |
| Profit | - | (3.2m) | (11.5m) | (27.4m) | - |
| % profit margin | - | (158329 %) | (6621 %) | (13175 %) | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$9.2m | Seed | ||
£350k | Grant | ||
£23.0m | Series A | ||
* | $100m | Series B | |
| Total Funding | CAD191m | ||
Recent News about Ori Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.